Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 682 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Of SYNC-T Therapy SV-102 In Participants With Metastatic Castration-Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Pafolacianine For Localization Of Pediatric Extracranial Solid Tumors

    Rochester, MN

  3. A Phase I Study Of [225Ac]-AZD2284 In Patients With Metastatic Castration-Resistant Prostate Cancer

    Rochester, MN

  4. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Investigate Ubamatamab With And Without Marlotamig (REGN7075) In Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

  6. Study Of JANX007 In Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Lung-MAP: A Master Screening Protocol For Previously-Treated Non-Small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  8. Fucoidan For Preventing Chemotherapy-Related Fatigue In Patients With Gastrointestinal Or Gynecological Cancer

    Scottsdale/Phoenix, AZ

  9. Saruparib (AZD5305) Plus Camizestrant Or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer

    Jacksonville, FL, Rochester, MN

  10. Using 18F-FAPI PET To Detect Metastatic Disease In Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

    Rochester, MN

.

Mayo Clinic Footer